KalVista Pharmaceuticals, Inc. (FRA:4XC1)
Germany · Delayed Price · Currency is EUR 12.60
+0.10 (0.80%)
At close: Dec 19, 2025
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of €656.96 million as of December 22, 2025. Its market cap has increased by 48.60% in one year.
Market Cap
656.96M
Enterprise Value
634.28M
Revenue
1.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
€12.60
Market Cap Chart
Since November 23, 2016, KalVista Pharmaceuticals's market cap has increased from 78.86M to 656.96M, an increase of 733.11%. That is a compound annual growth rate of 26.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 656.96M | 62.50% |
| Dec 31, 2024 | 404.30M | 5.56% |
| Dec 29, 2023 | 383.00M | 77.55% |
| Dec 30, 2022 | 215.71M | -24.22% |
| Dec 31, 2021 | 284.66M | 2.20% |
| Dec 31, 2020 | 278.54M | -1.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |